title: Infliximab-induced cerebral thrombophlebitis.
authors.forename: L
authors.initials: L
authors.lastname: Grange
authors.forename: M J
authors.initials: MJ
authors.lastname: Nissen
authors.forename: K
authors.initials: K
authors.lastname: Garambois
authors.forename: A
authors.initials: A
authors.lastname: Dumolard
authors.forename: C
authors.initials: C
authors.lastname: Duc
authors.forename: P
authors.initials: P
authors.lastname: Gaudin
authors.forename: R
authors.initials: R
authors.lastname: Juvin
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D018501:Antirheumatic Agents / Q000009:adverse effects*; D006801:Humans; D000069285:Infliximab; D020767:Intracranial Thrombosis / Q000139:chemically induced*; D018810:Magnetic Resonance Angiography; D008297:Male; D013167:Spondylitis, Ankylosing / Q000188:drug therapy; D013924:Thrombophlebitis / Q000139:chemically induced*
chemical_list: D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D000069285:Infliximab